Soo Hyun (Esther) Kim, M.D.
| Appointed: |
2008 |
| Gender: |
Female |
| Languages: |
English |
Vascular Medicine
Biographical Sketch
Soo Hyun (Esther) Kim MD, MPH is a staff physician in the Department of Cardiovascular Medicine specializing in the diagnosis and treatment of vascular disease. She joined the staff in 2008 after completing fellowships at Cleveland Clinic in cardiology and vascular medicine.
A graduate of Duke University School of Medicine in Durham, N.C., Dr. Kim also holds a Master’s in Public Health from the University of North Carolina, Chapel Hill. She completed a residency in Internal Medicine at Johns Hopkins Hospital before coming to Cleveland Clinic for her fellowships.
Dr. Kim has co-authored and edited chapters for several books related to the diagnosis and treatment of peripheral vascular disease, including the Manual of Cardiovascular Medicine, edited by Brian Griffin, MD, and Eric Topol, MD, published by Lippincott Williams & Wilkins in 2009. She is an award-winning researcher, including the 2007 American College of Cardiology Young Investigator Award.
Dr. Kim is board certified in Internal Medicine and Diagnostic Medical Sonography as a Registered Physician in Vascular Interpretation (RPVI). She is a member of the American Heart Association, the American College of Cardiology, and the Society of Vascular Medicine.
Education & Fellowships
| Medical School: | Duke University School of Medicine, Durham, NC |
|
| Residency: | Johns Hopkins Hospital, Internal Medicine, Baltimore, MD |
| Fellowship: | Cleveland Clinic, Cardiology, Cleveland, OH |
| Other Education: | (Graduate) University of North Carolina at Chapel Hill, Chapel Hill, NC |
| Other Education: | (Undergraduate) Duke University, Durham, NC |
Certifications
Cardiovascular Disease
Internal Medicine
Professional Memberships
- American College of Cardiology
- American Heart Association
- Society of Vascular Medicine
Specializes in Diseases and Conditions
Specializes in Services
Industry Relationships
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical education about recent trends. The collaborations are reviewed as part of the Cleveland Clinic’s procedures. The Cleveland Clinic publicly discloses payments to its physicians and scientists for speaking and consulting of $5,000 or more per year, and any equity, royalties, and fiduciary relationships in companies with which they collaborate. The Cleveland Clinic requires its doctors to approve the public disclosures of their scientific collaborations with industry. As of 5/29/2009 the review process regarding Dr. Kim’s disclosure had not been completed. Patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic’s policies on collaborations with industry and innovation management, go to our
Integrity in Innovation page.
( † Disclaimer: This search is powered by PubMed, a service of the U.S.
National Library of Medicine. PubMed is a third-party website with no
affiliation with Cleveland Clinic.)
